# Arbutus Biopharma Corp: Form 8-K, filed Jun 28, 2021

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2021-06-28
- Accepted by EDGAR: Jun 28, 2021, 08:00 ET
- Period: 2021-06-26
- Accession: 0001171843-21-004544
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000117184321004544/f8k_062621.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000117184321004544/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000117184321004544/f8k_062621.htm

Filed Jun 28, 2021.
Source: SEC EDGAR, the filing index for accession 0001171843-21-004544. Last ingested by Listed: Nov 10, 2026, 16:58 ET. No prices; not investment advice.